Huanxin Lin
Guangzhou, 510006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Design of an activatable unimolecular multicargo prodrug to deliver diethyldithiocarbamate and copper for targeted ovarian cancer therapy.
Journal: Chemical communications (Cambridge, England)
Published: July 21, 2026
A copper-based ascorbic acid-activatable gel for postoperative glioblastoma therapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 18, 2025
A ROS/photo dual-responsive prodrug unimolecular micelle for boosted cancer immunotherapy.
Journal: Asian journal of pharmaceutical sciences
Published: April 25, 2025
A fibroblast activation protein α-activatable nanoagent co-delivering diethyldithiocarbamate and copper for tumor therapy and imaging.
Journal: Acta biomaterialia
Published: May 13, 2024
Significance of Pre-Treatment CALLY Score Combined with EBV-DNA Levels for Prognostication in Non-Metastatic Nasopharyngeal Cancer Patients: A Clinical Perspective.
Journal: Journal of inflammation research
Published: January 17, 2024
Prognostic value and immune landscapes of TERT promoter methylation in triple negative breast cancer.
Journal: Frontiers in immunology
Published: May 08, 2023
A new autophagy-related nomogram and mechanism in multiple myeloma.
Journal: Genes & diseases
Published: February 18, 2023
Neutrophil extracellular traps (NETs)-related lncRNAs signature for predicting prognosis and the immune microenvironment in breast cancer.
Journal: Frontiers in cell and developmental biology
Published: December 06, 2022
A Prognostic Model Based on Nutritional Risk Index in Operative Breast Cancer.
Journal: Nutrients
Published: August 12, 2022
A Novel Inflammatory-Nutritional Prognostic Scoring System for Patients with Early-Stage Breast Cancer.
Journal: Journal of inflammation research
Published: September 09, 2021
Last Updated: 09/26/2026